Schedule 13G ownership disclosure
XBIOTECH INC
Common Shares, no par value · CUSIP: 98400H102
Event date: 2025-12-31
- Filing-level shares
- 3,006,259.00
- Percent of class
- 9.76%
- W. Thorpe McKenzie
Shares: 3,006,259.00 · Class: 9.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171843-26-000406
- Form type
- SCHEDULE 13G/A
- Filer
- MCKENZIE W THORPE
- CIK
- CIK 1211462
- Filed
- Jan 23, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership